Treatment of persistent tachycardia with dexmedetomidine during off-pump cardiac surgery.

  Autonomic nervous system responses during sedative infusions of dexmedetomidine.

  Bispectral index-guided sedation with dexmedetomidine in intensive care: a prospective, randomized, double blind, placebo-controlled phase II study.

  Pharmacokinetics of dexmedetomidine infusions for sedation of postoperative patients requiring intensive care.

  The efficacy, side effects, and recovery characteristics of dexmedetomidine versus propofol when used for intraoperative sedation.

  Dexmedetomidine to facilitate drug withdrawal

  The effect of intravenous dexmedetomidine premedication on the dose requirement of propofol to induce loss of consciousness in patients receiving alfentanil.

  Effect of dexmedetomidine, an alpha2-adrenoceptor agonist, on human pupillary reflexes during general anaesthesia.

  Comparison between dexmedetomidine and propofol for sedation in the intensive care unit: patient and clinician perceptions.

  Preliminary UK experience of dexmedetomidine, a novel agent for postoperative sedation in the intensive care unit.

  Comparison of dexmedetomidine and midazolam sedation and antagonism of dexmedetomidine with atipamezole.

  Effects of intravenous dexmedetomidine in humans. I. Sedation, ventilation, and metabolic rate.

  Effect of dexmedetomidine and midazolam on human performance and mood.

  Effect of dexmedetomidine on propofol requirements in healthy subjects.

  Sedative, amnestic, and analgesic properties of small-dose dexmedetomidine infusions.

  Effects of dexmedetomidine on adrenocortical function, and the cardiovascular, endocrine and inflammatory responses in post-operative patients needing sedation in the intensive care unit.

  Use of propofol and other nonbenzodiazepine sedatives in the intensive care unit.

  Initial experience with dexmedetomidine in pediatric aged patients.

  Effect of dexmedetomidine on propofol requirements in healthy subjects.

  The effects of increasing plasma concentrations of dexmedetomidine in humans.

    Back to Summaries List